A pharmacological study of bronchodilator properties of NKH477, forskolin, and β-agonists on guinea pig and ovine isolated bronchioles

Drug Development Research

Volumn 51, Issue 3, 2000, Pages 169-176

  Yousif, Mariam H M ^a   Thulesius, Olav ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Bronchioles; Cyclic AMP; Forskolin; NKH477; Salbutamol; Tachyphylaxis

Indexed keywords

6 (3 DIMETHYLAMINOPROPIONYL)FORSKOLIN; ADENYLATE CYCLASE ACTIVATOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FORSKOLIN; ISOPRENALINE; SALBUTAMOL;

ANIMAL TISSUE; ARTICLE; BRONCHODILATATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; GUINEA PIG; NONHUMAN; TACHYPHYLAXIS; TISSUE PREPARATION;

EID: 0034491473     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2299(200011)51:3<169::AID-DDR5>3.0.CO;2-8     Document Type: Article

References (14)

1. Bulbring E, Tomita T. 1987. Catecholamine action on smooth muscle. Pharmacol Rev 39:49-96.
2. Emala C, Black C, Curry C, Levine MA, Hirshman CA. 1993. Impaired beta-adrenergic receptor activation of adenylyl cyclase in airway smooth muscle in the basenji-greyhound dog model of airway hyper-responsiveness. Am J Res Cell Mol Biol 8:668-675.
3. Hosono M, Takahira T, Fujita A, Fujihara R, Ishizuka O, Tatee T, Nakamura K. 1992. Cardiovascular and adenylate cyclase stimulant properties of NKH477, a novel water-soluble forskolin derivative. J Cardiovasc Pharmacol 19:623-634.
4. s on desensitization of β-adrenergic receptors in tracheal smooth muscle. Am J Physiol 273:L556-L564.
5. Larsson K, Martinsson A, Hjemdhal R 1992. Influence of β-adrenergic receptor function during terbutaline treatment on allergen sensitivity and bronchodilator response to terbutaline in asthmatic subjects. Chest 101:953-960.
6. Ljusegren ME, Ahlner J, Axelsson K. 1988. Studies on vascular smooth muscle tolerance to different cGMP-mediated vasodilators and cross-tolerance to glyceryl trinitrate. Pharmacol Toxicol 62:302-307.
7. Miao FJ, Lee TJ. 1992. Regional variation in acute vascular homologous tachypliylaxis. J Pharmacol Exp Ther 260:644-651.
8. Muller M, Baer H. 1983. Relaxant effects of forskolin in smooth muscle. Role of cyclic AMR. Naunyn Schmiedebergs Arch Pharmacol 322:78-82.
9. 2-adrenoceptors. Gen Pharmacol 28:753-756.
10. + channels. Br J Pharmacol 123:753-761.
11. Seamon K, Daly J. 1981. Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J Cyclic Nucleotide Res 7:201-224.
12. Seamon K, Daly J. 1983. Forskolin, cyclic AMP and cellular physiology. Trends Pharmacol Sci 4:120-123.
13. Seamon K, Padgett W, Daly J. 1981. Forskolin-unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci USA. 78:3363-3367.
14. 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology. Drug Saf 11:59-283.